Indeed, perturbed expression of key cholesterol biosynthesis enzymes, such as HMGCR and SQLE, prevents carcinogenesis in colorectal cancer, breast cancer, prostate cancer and hepatocellular carcinoma associated with nonalcoholic fatty liver disease (NAFLD-HCC) [18–22]. This evidence concerns the gene SQLE and hepatocellular carcinoma.